Agilent Technologies Inc (NYSE:A) SVP Dominique Grau sold 9,033 shares of Agilent Technologies stock in a transaction that occurred on Friday, January 17th. The shares were sold at an average price of $90.00, for a total transaction of $812,970.00. Following the completion of the transaction, the senior vice president now owns 106,530 shares of the company’s stock, valued at approximately $9,587,700. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Dominique Grau also recently made the following trade(s):
- On Wednesday, December 11th, Dominique Grau sold 15,000 shares of Agilent Technologies stock. The shares were sold at an average price of $82.85, for a total transaction of $1,242,750.00.
NYSE A opened at $90.13 on Thursday. The company has a quick ratio of 1.21, a current ratio of 1.53 and a debt-to-equity ratio of 0.38. Agilent Technologies Inc has a 52 week low of $65.35 and a 52 week high of $90.64. The stock has a market capitalization of $27.80 billion, a PE ratio of 28.72, a price-to-earnings-growth ratio of 2.10 and a beta of 1.42. The firm has a 50 day moving average of $85.54 and a two-hundred day moving average of $76.88.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.80%. The ex-dividend date was Monday, December 30th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.16. Agilent Technologies’s payout ratio is currently 23.15%.
A number of brokerages recently weighed in on A. Stifel Nicolaus started coverage on shares of Agilent Technologies in a report on Thursday, November 14th. They issued a “hold” rating and a $85.00 price objective for the company. Citigroup started coverage on shares of Agilent Technologies in a report on Monday, January 6th. They set a “neutral” rating and a $85.00 price target for the company. JPMorgan Chase & Co. boosted their price target on shares of Agilent Technologies from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, November 26th. UBS Group boosted their price target on shares of Agilent Technologies from $82.00 to $87.00 and gave the stock a “neutral” rating in a report on Tuesday, November 26th. Finally, Barclays lowered their price target on shares of Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating for the company in a report on Wednesday, October 9th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $84.57.
Large investors have recently modified their holdings of the company. WealthStone Inc. purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth approximately $31,000. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Agilent Technologies by 185.5% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 471 shares of the medical research company’s stock worth $36,000 after buying an additional 306 shares during the last quarter. Doyle Wealth Management purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth approximately $37,000. NuWave Investment Management LLC lifted its position in shares of Agilent Technologies by 1,184.1% during the 3rd quarter. NuWave Investment Management LLC now owns 565 shares of the medical research company’s stock worth $42,000 after buying an additional 521 shares during the last quarter. Finally, CSat Investment Advisory L.P. lifted its position in shares of Agilent Technologies by 409.3% during the 2nd quarter. CSat Investment Advisory L.P. now owns 769 shares of the medical research company’s stock worth $57,000 after buying an additional 618 shares during the last quarter.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Story: S&P/TSX Index
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.